Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/ZyVersa Therapeutics, Inc./ 8-K

Current Report · Items 8.01 · 8-K

ZyVersa Therapeutics, Inc.

Other Events

Item 8.01 Other Events. Effective July 16, 2026, ZyVersa Therapeutics, Inc. ceased trading on the OTCQB® Venture Market and commenced trading on the OTC Pink Limited Market.

Filed Jul 16, 2026Accepted Jul 16, 2026, 5:00 PM EDTCIK 1859007Accession 0001493152-26-033565
View company →Permanent SEC source ↗
Share

Company context

Current securities

ZVSAOTC · EQUITY · Current
Historical securities (6)
LSPRNASDAQ · EQUITY · Historical · closed Dec 12, 2022LSPRUNASDAQ · UNIT · Historical · closed Dec 12, 2022LSPRWNASDAQ · WARRANT · Historical · closed Dec 12, 2022ZVSANASDAQ · EQUITY · Historical · closed Jul 16, 2025ZVSAOTC · EQUITY · Historical · closed Oct 19, 2026ZVSAWNASDAQ · WARRANT · Historical · closed Dec 20, 2022

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsJul 10, 2026
  2. 10-Q filingMay 13, 2026

Registered securities in this filing

ZYVERSA THERAPEUTICS, INC. · 8-K · Filed 2026-07-16

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.0001 per share

Symbol
ZVSA
Exchange
Not supplied
Classification
COMMON
Filing context

Context: AsOf2026-07-16

Dimensions: Not supplied

Accession 000149315226033565 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 8.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. Effective July 16, 2026, ZyVersa Therapeutics, Inc. ceased trading on the OTCQB® Venture Market and commenced trading on the OTC Pink Limited Market.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.